SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031982
Filing Date
2021-12-20
Accepted
2021-12-20 08:05:25
Documents
15
Period of Report
2021-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41945
2 ex99-1.htm EX-99.1 24375
3 image_001.jpg GRAPHIC 4677
  Complete submission text file 0001493152-21-031982.txt   300148

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hrow-20211217.xsd EX-101.SCH 3748
5 XBRL DEFINITION FILE hrow-20211217_def.xml EX-101.DEF 27053
6 XBRL LABEL FILE hrow-20211217_lab.xml EX-101.LAB 37298
7 XBRL PRESENTATION FILE hrow-20211217_pre.xml EX-101.PRE 25668
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5544
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 211503690
SIC: 2834 Pharmaceutical Preparations